Bachem AG and GlyTech, Inc. Announce Co-promotion Agreement

Bachem AG (Bubendorf, Switzerland), the leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), the world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech’s glycosylation technology. As part of the agreement, Bachem will leverage its sales and marketing resources to enhance GlyTech’s partnering efforts and GlyTech will promote Bachem as the partner of choice for manufacture of its glycopeptides and glycoproteins.
Bachem AG and GlyTech, Inc. Announce Co-promotion Agreement

Last updated: October 7th, 2014

Back to index of news